Optiscan’s InVue surgery imaging tech heads to US FDA

Optiscan Imaging has lodged a 510(k) submission with the US Food and Drug Administration (FDA) for its InVue precision surgery device, moving the technology into formal regulatory…

MediaNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.theaustralian.com.au)